Literature DB >> 3308667

Pancreatic hormones and amino acid levels following liver transplantation.

A Francavilla1, L Polimeno, D H Van Thiel, S Todo, I Kam, S Lynch, T E Starzl.   

Abstract

Glucose intolerance, hyperinsulinemia, peripheral insulin resistance and hyperglucagonemia are common in patients with advanced liver disease. These abnormalities in the plasma levels of the pancreatic hormones, insulin and glucagon have been thought to be responsible, at least in part, for the abnormal plasma ratio of branched-chain amino acids to aromatic amino acids. To evaluate this issue, plasma levels of glucose, insulin, glucagon, C-peptide and the branched-chain and aromatic amino acids were measured before and serially after orthotopic liver transplantation in 9 humans and 5 dogs. The abnormal plasma amino acid levels rapidly improved and achieved normal levels following orthotopic liver transplantation. Insulin levels also became normal following orthotopic liver transplantation, despite enhanced insulin secretion documented by an even further increased level of C-peptide. In contrast, the baseline abnormal plasma glucagon levels which are commonly seen in cirrhotics became even more abnormal following orthotopic liver transplantation. Despite this progressive increase in the abnormally elevated plasma glucagon levels, plasma amino acid levels, both branched-chain and aromatic, became normal. These data demonstrate that before and after orthotopic liver transplantation, there is: (i) no relationship between the changes in the plasma levels of glucagon and changes observed in the plasma level of amino acids; and (ii) plasma insulin and amino acid levels change in the same direction. In addition, these changes in plasma insulin and amino acid levels following orthotopic liver transplantation occur despite enhanced secretion of insulin evidenced by the progressive increase in plasma levels of C-peptide.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308667      PMCID: PMC2978927          DOI: 10.1002/hep.1840070521

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  28 in total

1.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

2.  Glucose intolerance and insulin resistance in patients with liver disease.

Authors:  J R Collins; O B Crofford
Journal:  Arch Intern Med       Date:  1969-08

3.  Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.

Authors:  R S Sherwin; M Fisher; R Hendler; P Felig
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

4.  Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.

Authors:  F J Dudley; F P Alford; D J Chisholm; D M Findlay
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

5.  Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells.

Authors:  R P Robertson
Journal:  Diabetes       Date:  1986-09       Impact factor: 9.461

6.  Direct effects of cyclosporin A on human pancreatic beta-cells.

Authors:  J H Nielsen; T Mandrup-Poulsen; J Nerup
Journal:  Diabetes       Date:  1986-09       Impact factor: 9.461

7.  Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats.

Authors:  H J Hahn; F Laube; S Lucke; I Klöting; K D Kohnert; R Warzock
Journal:  Transplantation       Date:  1986-01       Impact factor: 4.939

8.  Leucine uptake by splanchnic and leg tissues in man: relative independence of insulin levels.

Authors:  L S Eriksson; L Hagenfeldt; P Felig; J Wahren
Journal:  Clin Sci (Lond)       Date:  1983-11       Impact factor: 6.124

9.  Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy.

Authors:  G Marchesini; G Forlani; M Zoli; A Angiolini; M P Scolari; F B Bianchi; E Pisi
Journal:  Dig Dis Sci       Date:  1979-08       Impact factor: 3.199

10.  Hormonal and metabolic changes in hepatic cirrhosis.

Authors:  D G Johnston; K G Alberti; C Binder; O K Faber; R Wright; H Orskov
Journal:  Horm Metab Res       Date:  1982-01       Impact factor: 2.936

View more
  1 in total

1.  Serum hepatocyte growth factor as an index of extensive catabolism of patients awaiting liver transplantation.

Authors:  C Miki; A D Mayer; J A Buckels; K Iriyama; H Suzuki; P McMaster
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.